Jump to main content
Jump to site search

Issue 8, 2006
Previous Article Next Article

Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4

Author affiliations

Abstract

A number of furanocoumarins isolated from grapefruit juice have been found to inhibit CYP3A4 activity in vitro. In this study, we have designed and synthesised a range of analogues based on bergamottin to investigate the relationship between chemical structure and inhibition of CYP3A4 activity. Studies were performed using human liver microsomes and human intestinal S9 fraction, with testosterone as the marker substrate. With the exception of the coumarin and phenolic furanocoumarin derivatives, which were inactive, the alkyloxy-furanocoumarin analogues were found to inhibit CYP3A4 activity in a dose dependent manner, with observed IC50 values ranging from 0.13 ± 0.03 to 49.3 ± 1.9 µM. The unsaturated furan derivatives were found to exhibit time-dependent inhibition, showing a 2-, 4- and 14-fold increase in potency for 6′,7′-epoxybergamottin, 6′,7′-dihydroxybergamottin and bergamottin, respectively after a preincubation period of ten minutes. Reduction of the furan moiety resulted in an 11-fold decrease in inhibitory potency, suggesting that this functional group is key to the interaction between these compounds and CYP3A4.

Graphical abstract: Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4

Back to tab navigation
Please wait while Download options loads

Publication details

The article was received on 23 Jan 2006, accepted on 23 Feb 2006 and first published on 20 Mar 2006


Article type: Paper
DOI: 10.1039/B601096B
Citation: Org. Biomol. Chem., 2006,4, 1604-1610
  •   Request permissions

    Design, synthesis and evaluation of furanocoumarin monomers as inhibitors of CYP3A4

    E. C. Row, S. A. Brown, A. V. Stachulski and M. S. Lennard, Org. Biomol. Chem., 2006, 4, 1604
    DOI: 10.1039/B601096B

Search articles by author